Kato Seiichi, Nakayama Keiko, Minoura Takanori, Konno Mutsuko, Tajiri Hitoshi, Matsuhisa Takeshi, Iinuma Kazuie
Department of Pediatrics, Tohoku University School of Medicine, 1-1 Seiryo-machi, Aoba-ku, 980-8574, Sendai, Japan.
J Gastroenterol. 2004 Nov;39(11):1045-50. doi: 10.1007/s00535-004-1442-6.
As noninvasive tests for Helicobacter pylori infection, the 13C-urea breath test (UBT) and stool antigen test have been widely used. In children, however, there are few studies reporting which test shows superior performance. The purpose of this study was to compare the 13C-UBT and stool antigen test for their accuracy in diagnosing H. pylori infection in children.
A total of 123 Japanese children, ages 2 to 17 years (mean, 12 years) who underwent gastric biopsies for H. pylori infection were studied. The diagnoses included gastritis (n = 55), gastric ulcer (n = 5), duodenal ulcer (n = 20), iron-deficiency anemia (n = 7), and other conditions (n = 36). The cutoff value of the 13C-UBT was defined to be 3.5 per thousand. The stool antigen test was performed using the HpSA enzyme-linked immunosorbent assay (ELISA) (Premier Platinum HpSA). In 16 patients who received eradication therapy, the 13C-UBT and HpSA were repeated 2 months after treatment.
Based on biopsy tests, 60 children were infected with H. pylori and 63 children were not. For the 13C-UBT, the sensitivity, specificity, and accuracy were 95.0% (95% confidence interval [CI], 86.1%-99.0%), 98.4% (95% CI, 91.5%-100%), and 96.4% (95% CI, 93.6%-99.9%), respectively. For the HpSA, the sensitivity, specificity, and accuracy were 98.3% (95% CI, 90.8%-100%), 98.4% (95% CI, 91.2%-100%), and 98.3% (95% CI, 96.0%-100%), respectively. There were no significant differences between the performance of these two tests. In the assessment of H. pylori eradication, the results of 13C-UBT and HpSA agreed with those of biopsy tests.
The 13C-UBT and the HpSA are equally accurate for the diagnosis of active H. pylori infection in Japanese children.
作为幽门螺杆菌感染的非侵入性检测方法,13C尿素呼气试验(UBT)和粪便抗原检测已被广泛应用。然而,在儿童中,很少有研究报告哪种检测方法表现更优。本研究的目的是比较13C-UBT和粪便抗原检测在诊断儿童幽门螺杆菌感染方面的准确性。
对123名年龄在2至17岁(平均12岁)因幽门螺杆菌感染接受胃活检的日本儿童进行了研究。诊断包括胃炎(n = 55)、胃溃疡(n = 5)、十二指肠溃疡(n = 20)、缺铁性贫血(n = 7)和其他病症(n = 36)。13C-UBT的临界值定义为3.5‰。粪便抗原检测采用HpSA酶联免疫吸附测定(ELISA)(Premier Platinum HpSA)。在16名接受根除治疗的患者中,治疗2个月后重复进行13C-UBT和HpSA检测。
根据活检检测,60名儿童感染了幽门螺杆菌,63名儿童未感染。对于13C-UBT,敏感性、特异性和准确性分别为95.0%(95%置信区间[CI],86.1%-99.0%)、98.4%(95%CI,91.5%-100%)和96.4%(95%CI,93.6%-99.9%)。对于HpSA,敏感性、特异性和准确性分别为98.3%(95%CI,90.8%-100%)、98.4%(95%CI,91.2%-100%)和98.3%(95%CI,96.0%-100%)。这两种检测方法的性能之间没有显著差异。在评估幽门螺杆菌根除情况时,13C-UBT和HpSA的结果与活检检测结果一致。
13C-UBT和HpSA在诊断日本儿童活动性幽门螺杆菌感染方面同样准确。